海洋バイオテクノロジー市場規模、シェア、成長分析、タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測、2025-2032年

海洋バイオテクノロジーの世界市場規模は、2023年に65億米ドルと評価され、2024年の69億5,000万米ドルから2032年には118億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.9％で成長する見通しです。

世界の海洋バイオテクノロジー市場は上昇基調にあり、海洋資源を活用して医療、農業、エネルギー分野を革新しています。この急成長産業は、持続可能で環境に優しい代替品への需要、慢性疾患の蔓延、再生可能エネルギー源の追求が原動力となっています。しかし、研究開発費の高騰、海洋資源へのアクセス制限、規制上の障壁といった課題が、急速な成長を妨げています。とはいえ、バイオテクノロジーとゲノミクスの進歩は、産業界と研究機関の協力関係の高まりとともに、市場拡大を後押しする態勢を整えています。世界の主な動向には、産業プロセスにおける海洋由来酵素の採用や、医療や組織工学への応用を目的とした海洋バイオマテリアルへの関心の高まりなどがあり、世界の持続可能性の要請が強まる中、成長とイノベーションの大きな機会が示唆されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

海洋バイオテクノロジー市場規模：タイプ別

• 市場概要
• バイオアクティブ物質
• バイオマテリアル

海洋バイオテクノロジー市場規模：技術別

• 市場概要
• 微生物の分離と培養
• 培養に依存しない技術

海洋バイオテクノロジー市場規模：用途別

• 市場概要
• 水産養殖および食品
• 環境と人間の健康
• 創薬

海洋バイオテクノロジー市場規模：エンドユーザー別

• 市場概要
• 食品産業
• 製薬・バイオテクノロジー産業
• 化学産業
• 化粧品業界

海洋バイオテクノロジー市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• BASF（Germany）
• Key Developments
• Cyanotech Corp.（USA）
• Kerry Group（Ireland）
• Corbion（Netherlands）
• FMC Corp.（USA）
• Marine Biotech（USA）
• Royal DSM（Netherlands）
• TransGen Biotech Co., Ltd.（China）
• Olmix Group（France）
• Ittinsect（Italy）
• BRAIN Biotech AG（Germany）
• Biotech Marine（France）
• Marinova Pty Ltd（Australia）
• Pharma Mar, S.A.（Spain）
• GlycoMar Ltd.（UK）
• Aker BioMarine ASA（Norway）
• oceanBASIS GmbH（Germany）
• Primex Iceland（Iceland）
• New England Biolabs（NEB）（USA）

結論と提言

Global Marine Biotechnology Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 6.95 billion in 2024 to USD 11.85 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global marine biotechnology market is on an upward trajectory, leveraging oceanic resources to innovate in medicine, agriculture, and energy sectors. This burgeoning industry is driven by the demand for sustainable, eco-friendly alternatives, heightened chronic disease prevalence, and the pursuit of renewable energy sources. Yet, challenges such as high R&D costs, limited access to marine resources, and regulatory barriers impede rapid growth. Nonetheless, advancements in biotechnology and genomics, along with rising collaborations between industry and research organizations, are poised to propel market expansion. Key trends include the adoption of marine-derived enzymes in industrial processes and a growing interest in marine biomaterials for applications in medicine and tissue engineering, suggesting significant opportunities for growth and innovation as global sustainability imperatives intensify.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Marine Biotechnology Market Segments Analysis

Global Marine Biotechnology Market is segmented by Type, Technology, Application, End-user and region. Based on Type, the market is segmented into Bio Active Substance and Bio Materials. Based on Technology, the market is segmented into Isolation and Cultivation of Microorganisms and Culture-Independent Techniques. Based on Application, the market is segmented into Aquaculture and Food Products, Environment & Human Health and Drug Discovery. Based on End-user, the market is segmented into Food Industry, Pharmaceutical and Biotechnology Industry, Chemical Industry and Cosmetic Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Marine Biotechnology Market

Rising awareness of environmental issues and the push for sustainability are driving demand for eco-friendly products in numerous sectors. Marine biotechnology emerges as a key player in this movement, providing sustainable solutions like marine-derived enzymes for industrial uses, alongside biofuels and bioplastics. One notable example is Algix, a company that creates biodegradable bioplastic materials sourced from algae, presenting a sustainable alternative to conventional plastics. The integration of these innovative marine-derived solutions is not only addressing ecological concerns but also promoting a transition towards greener practices across various industries, highlighting the significant role of marine biotechnology in the global market.

Restraints in the Global Marine Biotechnology Market

The Global Marine Biotechnology market faces significant limitations due to the extensive research and development required for product innovation. This process includes identifying and cultivating marine organisms, alongside extracting and purifying bioactive compounds. Such intricate procedures come with high costs, which can hinder the growth and commercialization of marine biotechnology products. For instance, the cultivation and extraction of just one marine-derived compound can incur expenses totaling several hundred thousand dollars. This financial challenge poses a barrier for many companies seeking to enter and thrive in the market, ultimately impacting the industry's overall expansion and profitability.

Market Trends of the Global Marine Biotechnology Market

The Global Marine Biotechnology market is witnessing a significant trend towards the utilization of marine-derived biomaterials, driven by their unique properties and diverse applications in medicine, tissue engineering, and regenerative therapies. Innovations such as marine collagen, noted for its enhanced biocompatibility and biological functionality compared to traditional mammalian alternatives, are gaining traction in wound healing and tissue regeneration processes. The shift towards sustainable and biodegradable materials, coupled with increased research and development efforts, is propelling the demand for these biomaterials. This emerging trend highlights the potential of marine resources to revolutionize healthcare solutions and drive growth within the marine biotechnology sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Marine Biotechnology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Bio Active Substance
• Bio Materials

Global Marine Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Global Marine Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery

Global Marine Biotechnology Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Food Industry
• Pharmaceutical and Biotechnology Industry
• Chemical Industry
• Cosmetic Industry

Global Marine Biotechnology Market Size & CAGR (2025-2032)

• North America (Type, Technology, Application, End-user)
  • US
  • Canada
• Europe (Type, Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Cyanotech Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Biotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ittinsect (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRAIN Biotech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Marine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Mar, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aker BioMarine ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• oceanBASIS GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primex Iceland (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (NEB) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations